Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Angsana Provides Tests for Allergen Sensitization Specific for Asian Population

Wednesday, November 2, 2016 5:04
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Latest News

Reliance on Thermo Fisher Scientific Technology Will Ensure Improved Diagnostic Efficiency Which May Aid Better Allergy Management

SINGAPORE – Media OutReach – Nov 1, 2016 – Angsana Molecular & Diagnostics Laboratory today announced that it will provide tests for allergen sensitization specific for the Asian population using industry leading technology by Thermo Fisher Scientific. The tests will be based on Thermo Fisher’s ImmunoCAP technology and performed on Phadia Laboratory Systems.

Allergy constitutes a major health concern in both adolescents and adults. While many allergens are common across populations, there has been increased recognition of differences in the prevalence and morbidity of atopic diseases among different ethnic groups and across different geographic regions. Factors such as genetics, environmental exposure, diet and social behavior appear to contribute.

6019-angsana_logo_cmyk_1-jpg

Angsana is seeking to define and validate specific tests for allergen sensitization that are suited to local needs. ImmunoCAP technology is well known for its high specificity and sensitivity, quantitative results, high quality and a comprehensive menu of allergens and allergen components.

“Angsana is committed to deliver high-performance and affordable molecular diagnostic services to meet the health demand of Asian population. We are excited to work with Thermo Fisher and its technology to help us expand our service capabilities to better address this major public health concern,” said Dr. Chris Tan, Chief Executive Officer of Angsana. “With the rising incidence of atopic diseases, particularly among younger children, it is important to better understand the regional and ethnic differences in Asian countries,” said Dr. Richard Choy, Angsana’s Chief Scientific Officer and managing director of Angsana Hong Kong laboratory. “Through collaboration with local medical experts and healthcare providers, Angsana aims to provide a testing solution for Asia, in order to help improve the diagnosis efficiency and aid better allergy management.”

“We’re pleased that Angsana recognizes our quality and expertise and we are pleased that our technology can be used to support their efforts,” said [Stefan Wolf], president, ImmunoDiagnostics, Thermo Fisher. “Providing tests for allergen sensitization for the Asian population will help to enable healthcare professionals to have a better understanding of the symptoms of their patients.”

Angsana has recently acquired Allergy Laboratory, a Singapore-based private laboratory with over 10-year experience serving in the allergy testing business. “The acquisition enables us to combine the existing tests and dedicated expertise from Allergy Laboratory with the range of premium molecular assays from Angsana, providing an expanded, high-quality diagnostic services under the CAP-accredited environment” said Dr. Chris Tan from Angsana.

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.